ClinicalTrials.Veeva

Menu
S

Sheba Medical Center | Ella Lemelbaum Institute for Immuno-Oncology and Melanoma

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

EIK1001-006
Pembrolizumab

Parent organization

This site is a part of Sheba Medical Center

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

1 of 1 total trial

Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.

The study is for patients with advanced melanoma who are eligible for standard therapy with Pembrolizumab.

Enrolling
Advanced Melanoma
Drug: EIK1001
Drug: Pembrolizumab (KEYTRUDA® )

Trial sponsors

E

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems